Teva Pharmaceutical Industries Ltd has commercially launched generic version of Galderma's product, Differin (adapalene 0.1%) Gel after it received US Food and Drug Administration (FDA) approval. It is indicated for the treatment of acne.
The brand product had annual sales of approximately US$ 91 million in the United States, based on IMS sales data.
Teva Pharma is among the top 15 pharmaceutical companies in the world and is the leading generic pharmaceutical company.